- PRICING
- LIVE QUOTES
- LEARN
- HELP
EN
AnaptysBio's Transformation Into a Royalty Company Meets Its First Real Scorecard—Or Does It
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Based on available historical data, AnaptysBio has reported earnings at various times, with recent reports occurring before market open, meaning Day 0 represents the first reaction session and Day +1 captures follow-through trading.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-05-12 | -$2.34 (-3.45%) | $5.84 (8.61%) | -$2.89 (-4.41%) | $7.25 (11.06%) |
| 2026-03-03 | -$1.39 (-3.79%) | $1.37 (3.75%) | +$5.15 (+14.61%) | $5.68 (16.12%) |
| 2025-11-04 | -$0.87 (-3.61%) | $1.27 (5.27%) | +$0.84 (+3.63%) | $3.71 (16.03%) |
| 2025-08-06 | -$0.77 (-4.85%) | $1.02 (6.48%) | -$1.45 (-9.63%) | $2.27 (15.13%) |
| 2025-05-05 | -$0.31 (-2.17%) | $0.55 (3.92%) | -$0.41 (-2.94%) | $1.05 (7.62%) |
| 2025-02-27 | -$0.40 (-3.53%) | $0.79 (7.00%) | +$0.28 (+2.56%) | $2.48 (22.68%) |
| 2024-11-05 | -$0.04 (-0.30%) | $0.62 (4.66%) | +$1.55 (+11.72%) | $1.40 (10.56%) |
| 2024-08-05 | N/A | N/A | N/A | N/A |
| Avg Abs Move | 3.10% | 5.67% | 7.07% | 14.17% |
Historical price action around earnings shows significant volatility, with an average absolute Day 0 move of 3.10% and Day +1 move of 7.07%. The Day +1 range averages 14.17%, indicating substantial intraday swings as investors digest results.
The most recent earnings (May 2026) produced a -4.41% decline on Day +1 following the disappointing $-1.84 loss. However, the prior three reports showed more positive reactions: March 2026 surged +14.61% on Day +1 after the strong Q4 beat, November 2025 gained +3.63%, and August 2025 fell -9.63%. The pattern suggests the market rewards beats significantly and punishes misses, with the magnitude of the move often correlating to the size of the surprise.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 09/18/26 (DTE 3) |
| Expected Move | $2.93 (5.36%) |
| Expected Range | $51.75 to $57.61 |
| Implied Volatility | 100.34% |
The options market is pricing an expected move of 5.36% ($2.93) for this earnings release, which sits between the historical Day 0 average of 3.10% and the Day +1 average of 7.07%. This suggests options traders are anticipating a moderately volatile reaction—less dramatic than some recent earnings but still meaningful given the stock's unpredictable track record.
Part 3: What Analysts Are Saying
Analysts maintain a Strong Buy consensus on ANAB with an average rating of 4.82 out of 5.00. The current breakdown shows 10 Strong Buy ratings, 0 Moderate Buys, 1 Hold, and no Sell ratings among 11 analysts covering the stock.
The average price target of $86.80 implies 58.7% upside from the current price of $54.68, with estimates ranging from a low of $70.00 to a high of $140.00. This wide range reflects differing views on the value of the company's royalty streams and the success potential of its partnered assets.
Sentiment has deteriorated slightly from a month ago, when the consensus rating stood at 4.83 with 11 Strong Buys. One analyst appears to have downgraded from Strong Buy to Hold, though the overall bullish stance remains intact. The recent downgrade likely reflects concerns following the disappointing Q1 2026 results and uncertainty about the sustainability of the post-spin-off business model.
Part 4: Technical Picture
The Barchart Technical Opinion currently shows a Sell signal at 8%, unchanged from last week but representing a significant deterioration from last month's Buy signal at 56%. This sharp reversal reflects the stock's recent weakness as it has declined from higher levels.
Timeframe Analysis:
- Short-term (50% Sell): Moderate sell signal indicates near-term momentum has turned negative
- Medium-term (Hold): Neutral reading suggests the intermediate trend is in consolidation mode
- Long-term (50% Buy): Moderate buy signal reflects the stock's longer-term uptrend remains intact despite recent weakness
Trend Characteristics: The signal strength is classified as Weak with direction at Weakest, suggesting the current technical environment is fragile and lacks conviction heading into earnings.
The stock is trading at $54.68, positioned below all short-term moving averages: the 5-day ($54.70), 10-day ($55.55), 20-day ($56.68), 50-day ($57.02), and 100-day ($58.60). However, it remains above the 200-day moving average at $47.31, confirming the longer-term uptrend is still intact.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $54.70 | 50-Day MA | $57.02 |
| 10-Day MA | $55.55 | 100-Day MA | $58.60 |
| 20-Day MA | $56.68 | 200-Day MA | $47.31 |
The technical setup heading into earnings is cautionary. With the stock below all meaningful short-term moving averages and showing weak momentum, ANAB lacks technical support for a positive reaction unless results significantly exceed expectations. The 200-day moving average at $47.31 represents the critical long-term support level, while immediate resistance sits at the 50-day moving average of $57.02. Given the stock's tendency for large post-earnings moves and the current weak technical posture, risk management is particularly important for this release.